BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35655818)

  • 1.
    Sun HM; Wang LN; Ji M; Gan CT; Yuan YS; Cao XY; Zhang H; Zhang KZ
    Quant Imaging Med Surg; 2022 Jun; 12(6):3264-3275. PubMed ID: 35655818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurostructural correlates of BDNF rs6265 genotype in youth bipolar disorder.
    Kennedy KG; Shahatit Z; Dimick MK; Fiksenbaum L; Freeman N; Zai CC; Kennedy JL; MacIntosh BJ; Goldstein BI
    Bipolar Disord; 2022 Mar; 24(2):185-194. PubMed ID: 34263997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
    Gan Y; Su D; Zhang Z; Zhang Z; Yan R; Liu Z; Wang Z; Zhou J; Lam JST; Wu T; Jing J; Feng T
    Eur J Neurol; 2024 Feb; 31(2):e16147. PubMed ID: 37975786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered functional connectivity of cerebellar dentate nucleus in peak-dose dyskinesia in Parkinson's disease.
    Zhang H; Wang L; Gan C; Cao X; Ji M; Sun H; Yuan Y; Zhang K
    Front Aging Neurosci; 2022; 14():943179. PubMed ID: 36034152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder.
    Shen Z; Lu Y; Jiang H; Ye J; Zhou C; He M; Li N; Xu X; Cheng Y
    Neuroreport; 2020 Nov; 31(16):1146-1153. PubMed ID: 32991522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
    Fischer DL; Auinger P; Goudreau JL; Cole-Strauss A; Kieburtz K; Elm JJ; Hacker ML; Charles PD; Lipton JW; Pickut BA; Sortwell CE
    Neurotherapeutics; 2020 Oct; 17(4):1785-1795. PubMed ID: 33215284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia.
    Zhi Y; Wang M; Yuan YS; Shen YT; Ma KW; Gan CT; Si QQ; Wang LN; Cao SW; Zhang KZ
    Aging (Albany NY); 2019 Nov; 11(21):9661-9671. PubMed ID: 31699957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson's disease].
    Nikitina MA; Bragina EY; Nazarenko MS; Levchuk LA; Ivanova SA; Boiko AS; Gomboeva DE; Koroleva ES; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):114-120. PubMed ID: 38261293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats.
    Mercado NM; Stancati JA; Sortwell CE; Mueller RL; Boezwinkle SA; Duffy MF; Fischer DL; Sandoval IM; Manfredsson FP; Collier TJ; Steece-Collier K
    Neurobiol Dis; 2021 Jan; 148():105175. PubMed ID: 33188920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment.
    Luo Y; Chen H; Gui M
    Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease.
    Martinez-Carrasco A; Real R; Lawton M; Iwaki H; Tan MMX; Wu L; Williams NM; Carroll C; Hu MTM; Grosset DG; Hardy J; Ryten M; Foltynie T; Ben-Shlomo Y; Shoai M; Morris HR
    medRxiv; 2023 May; ():. PubMed ID: 37425912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.
    Santos-Lobato BL; Schumacher-Schuh AF; Rieder CRM; Hutz MH; Borges V; Ferraz HB; Mata IF; Zabetian CP; Tumas V
    Arq Neuropsiquiatr; 2020 Apr; 78(4):206-216. PubMed ID: 32294749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
    Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of childhood trauma and brain-derived neurotrophic factor Val66Met polymorphism on posttraumatic stress symptoms and cortical thickness.
    Jin MJ; Jeon H; Hyun MH; Lee SH
    Sci Rep; 2019 Apr; 9(1):6028. PubMed ID: 30988377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF rs6265 differentially influences neurometabolites in the anterior cingulate of healthy and bipolar disorder subjects.
    Scotti-Muzzi E; Chile T; Vallada H; Otaduy MCG; Soeiro-de-Souza MG
    Brain Imaging Behav; 2023 Jun; 17(3):282-293. PubMed ID: 36630045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNCA rs11931074 polymorphism correlates with spontaneous brain activity and motor symptoms in Chinese patients with Parkinson's disease.
    Si QQ; Yuan YS; Zhi Y; Wang M; Wang JW; Shen YT; Wang LN; Li JY; Wang XX; Zhang KZ
    J Neural Transm (Vienna); 2019 Aug; 126(8):1037-1045. PubMed ID: 31243602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.
    Kusters CDJ; Paul KC; Guella I; Bronstein JM; Sinsheimer JS; Farrer MJ; Ritz BR
    Parkinsonism Relat Disord; 2018 Feb; 47():39-44. PubMed ID: 29191473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.